Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Clay, AI"'
Autor:
Sucheston-Campbell, LE, Cannioto, R, Clay, AI, Etter, JL, Eng, KH, Liu, S, Battaglia, S, Hu, Q, Brian Szender, J, Minlikeeva, A, Joseph, JM, Mayor, P, Abrams, SI, Segal, BH, Wallace, PK, Soh, KT, Zsiros, E, Anton-Culver, H, Bandera, EV, Beckmann, MW, Berchuck, A, Bjorge, L, Bruegl, A, Campbell, IG, Campbell, SP, Chenevix-Trench, G, Cramer, DW, Mieszkowska, AD, Dao, F, Diergaarde, B, Doerk, T, Doherty, JA, Du Bois, A, Eccles, D, Engelholm, SA, Fasching, PA, Gayther, SA, Gentry-Maharaj, A, Glasspool, RM, Goodman, MT, Gronwald, J, Harter, P, Hein, A, Heitz, F, Hillemmanns, P, Høgdall, C, Høgdall, EVS, Huzarski, T, Jensen, A, Johnatty, SE, Jung, A, Karlan, BY, Klapdor, R, Kluz, T, Konopka, B, Kjer, SK, Kupryjanczyk, J, Lambrechts, D, Lester, J, Lubinski, J, Levine, DA, Lundvall, L, McGuire, V, McNeish, IA, Menon, U, Modugno, F, Ness, RB, Orsulic, S, Paul, J, Pearce, CL, Pejovic, T, Pharoah, P, Ramus, SJ, Rothstein, J, Rossing, MA, Rubner, M, Schildkraut, JM, Schmalfeldt, B, Schwaab, I, Siddiqui, N, Sieh, W
Publikováno v:
Sucheston-Campbell, LE; Cannioto, R; Clay, AI; Etter, JL; Eng, KH; Liu, S; et al.(2017). No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology Biomarkers and Prevention, 26(3), 420-424. doi: 10.1158/1055-9965.EPI-16-0631. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/51z1w9zq
© 2016 American Association for Cancer Research. Background: The precise mechanism by which the immune system is adversely affected in cancer patients remains poorly understood, but the accumulation of immunosuppressive/protumorigenic myeloid-derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::a63bbd5327726ba161d0022edf2f5d68
http://www.escholarship.org/uc/item/51z1w9zq
http://www.escholarship.org/uc/item/51z1w9zq
Autor:
Sucheston-Campbell LE; College of Pharmacy, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio., Cannioto R; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Clay AI; Cancer Genetic Epidemiology, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota., Etter JL; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Eng KH; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York., Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York., Battaglia S; Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York., Hu Q; Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York., Szender JB; Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Minlikeeva A; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Joseph JM; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Mayor P; Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Abrams SI; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York., Segal BH; Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York., Wallace PK; Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York., Soh KT; Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York., Zsiros E; Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Anton-Culver H; Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, California., Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina., Bjorge L; Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.; Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway., Bruegl A; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon., Campbell IG; Cancer Genetics Laboratory, East Melbourne, Australia.; Department of Pathology, University of Melbourne, Parkville, Victoria, Australia., Campbell SP; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon., Chenevix-Trench G, Cramer DW; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Dansonka-Mieszkowska A; Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Dao F; Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Diergaarde B; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania., Doerk T; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany., Doherty JA; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Eccles D; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, United Kingdom., Engelholm SA; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Gayther SA; Center for Cancer Prevention and Translational Genomics, Cedars-Sinai Medical Center, Los Angeles, California.; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California., Gentry-Maharaj A; Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Glasspool RM; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Goodman MT; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.; Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California., Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany., Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Hillemmanns P; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany., Høgdall C; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark., Høgdall EV; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark., Huzarski T; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Johnatty SE; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia., Jung A; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Klapdor R; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany., Kluz T; Clinic of Obstetrics and Gynecology, Institute of Midwifery and Emergency Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland., Konopka B; Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Kjær SK; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Kupryjanczyk J; Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Lambrechts D; Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center, University of Leuven, Leuven, Belgium., Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Lubiński J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Levine DA; Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York., Lundvall L; Department of Gynecology, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., McGuire V; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California., McNeish IA; Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom., Menon U; Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Modugno F; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania., Ness RB; The University of Texas School of Public Health, Houston, Texas., Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Paul J; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Pejovic T; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Pharoah P; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom., Ramus SJ; School of Women's and Children's Health, University of New South Wales, New South Wales, Australia.; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, New South Wales, New South Wales, Australia., Rothstein J; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California., Rossing MA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Epidemiology, University of Washington, Seattle, Washington., Rübner M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Schildkraut JM; Department of Public Health Sciences, The University of Virginia, Charlottesville, Virginia., Schmalfeldt B; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schwaab I; Praxis für Humangenetik, Wiesbaden, Germany., Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom., Sieh W; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Sobiczewski P; Department of Gynecologic Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom., Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Van Nieuwenhuysen E; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Vanderstichele A; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Vergote I; Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Walsh CS; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Australia., Wentzensen N; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland., Whittemore AS; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Ziogas A; Department of Epidemiology, University of California Irvine, Irvine, California., Odunsi K; Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany., Goode EL; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. kirsten.moysich@roswellpark.org.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2017 Mar; Vol. 26 (3), pp. 420-424. Date of Electronic Publication: 2016 Sep 27.